Evidence for Novel Hepaciviruses in Rodents - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue PLoS Pathogens Année : 2013

Evidence for Novel Hepaciviruses in Rodents

Stefan Klose
  • Fonction : Auteur
Beate Mareike Kümmerer
  • Fonction : Auteur
  • PersonId : 943843
Martin Beer
  • Fonction : Auteur
  • PersonId : 896827
Christian Drosten
  • Fonction : Auteur
  • PersonId : 925428


Hepatitis C virus (HCV) is among the most relevant causes of liver cirrhosis and hepatocellular carcinoma. Research is complicated by a lack of accessible small animal models. The systematic investigation of viruses of small mammals could guide efforts to establish such models, while providing insight into viral evolutionary biology. We have assembled the so-far largest collection of small-mammal samples from around the world, qualified to be screened for bloodborne viruses, including sera and organs from 4,770 rodents (41 species); and sera from 2,939 bats (51 species). Three highly divergent rodent hepacivirus clades were detected in 27 (1.8%) of 1,465 European bank voles (Myodes glareolus) and 10 (1.9%) of 518 South African four-striped mice (Rhabdomys pumilio). Bats showed anti-HCV immunoblot reactivities but no virus detection, although the genetic relatedness suggested by the serologic results should have enabled RNA detection using the broadly reactive PCR assays developed for this study. 210 horses and 858 cats and dogs were tested, yielding further horse-associated hepaciviruses but none in dogs or cats. The rodent viruses were equidistant to HCV, exceeding by far the diversity of HCV and the canine/equine hepaciviruses taken together. Five full genomes were sequenced, representing all viral lineages. Salient genome features and distance criteria supported classification of all viruses as hepaciviruses. Quantitative RT-PCR, RNA in-situ hybridisation, and histopathology suggested hepatic tropism with liver inflammation resembling hepatitis C. Recombinant serology for two distinct hepacivirus lineages in 97 bank voles identified seroprevalence rates of 8.3 and 12.4%, respectively. Antibodies in bank vole sera neither cross-reacted with HCV, nor the heterologous bank vole hepacivirus. Co-occurrence of RNA and antibodies was found in 3 of 57 PCR-positive bank vole sera (5.3%). Our data enable new hypotheses regarding HCV evolution and encourage efforts to develop rodent surrogate models for HCV.
Fichier principal
Vignette du fichier
journal.ppat.1003438.PDF (9.89 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-02395310 , version 1 (05-12-2019)





Jan Felix Drexler, Victor Max M Corman, Marcel Alexander Müller, Alexander N Lukashev, Anatoly Gmyl, et al.. Evidence for Novel Hepaciviruses in Rodents. PLoS Pathogens, 2013, 9 (6), pp.e1003438. ⟨10.1371/journal.ppat.1003438⟩. ⟨hal-02395310⟩
125 Consultations
174 Téléchargements



Gmail Facebook X LinkedIn More